Axinn partner Chad Landmon participated in a two-part video interview with Pharmacy Times. They discussed key events in the FDA pipeline, such as Emergency Use Authorizations during COVID-19 and the future of narrowed approvals. Click below to access the interviews.

Part 1: "Key Events in the FDA Pipeline During COVID-19"
Part 2: "The Future of Pharmaceuticals and the FDA Pipeline"